Protara Therapeutics TARA
NASDAQ TARA
$3.05 -0.16 (-4.98%)
At close: Sep 30, 2026 · 4:00 PM EDT

Protara Therapeutics (TARA) Total Non-Current Liabilities (2015 - 2016)

Updated

Protara Therapeutics (TARA) recorded Total Non-Current Liabilities of $4.84 million in Q3 2016, up 52.9% from $3.17 million a year earlier and up 7.7% from the prior quarter.

Analysis

Protara Therapeutics (TARA) Total Non-Current Liabilities (2015 - 2016) Analysis & Trends

At the end of FY2015, Protara Therapeutics reported Total Non-Current Liabilities of $3.6 million.

  • Per Business Quant, the preceding three quarters came in at $4.5 million (Q2 2016), $3.27 million (Q1 2016) and $3.6 million (Q4 2015).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 Protara Therapeutics 180.21 Mn 180.21 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2016 4.84 Mn
Jun 30, 2016 4.50 Mn
Mar 31, 2016 3.27 Mn
Dec 31, 2015 3.60 Mn
Sep 30, 2015 3.17 Mn
Jun 30, 2015 2.77 Mn
API Access

Protara Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=TARA&period=max&api_key=YOUR_API_KEY